ZAP-VAP
- 1 August 2019
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Advances in Neonatal Care
- Vol. 19 (4), 253-261
- https://doi.org/10.1097/anc.0000000000000635
Abstract
Ventilator-associated pneumonia (VAP) is the second most frequent hospital-acquired infection in neonatal intensive care units (NICUs) and significantly affects neonatal morbidity and mortality. The population most at risk for VAP are extremely preterm infants. The objectives of this quality improvement project were to create and evaluate the effectiveness of a VAP prevention bundle (“ZAP-VAP”) in reducing VAP. The development of the ZAP-VAP bundle and creation of audit tools were documented. A targeted gestational age less than 29 weeks was selected for this study. Electronic medical record review was used to determine the preintervention baseline for patient outcomes. Patient medical record data were analyzed retrospectively to measure patient outcomes preimplementation. VAP rates (number of VAP cases per 1000 ventilator days) were calculated pre- and postintervention. After implementation, data were analyzed prospectively to measure patient outcomes between neonates who developed VAP and those who did not. The VAP rate significantly decreased from 8.5 (2010-2011) to 2.5 (P = .0004) postintervention (2016). Median mechanical ventilation days decreased among VAP cases (47 vs 33 days) and slightly increased among non-VAP cases (19 vs 24 days) during the intervention period. Median length of stay decreased for VAP cases (136 vs 100 days) but remained unchanged for non-VAP cases (85 vs 84 days). The intervention was implemented from 2012 to 2016. The protocol was readily accepted by our neonatal intensive care unit (NICU) team through education and practice changes. ZAP-VAP is an effective and straightforward protocol that improved VAP outcomes in our level IIIB NICU. An interdisciplinary team successfully implemented this intervention for mechanically ventilated infants of all gestational ages in our unit and has been a model for these practice changes in other units and other hospitals. Future studies should focus on how to create sustainable interventions to decrease VAP in NICUs and to expand the approaches to other units in our hospital and other hospitals in our city among patients at risk for VAP.Keywords
This publication has 12 references indexed in Scilit:
- Ventilator-Associated Pneumonia in Low Birth Weight Neonates at a Neonatal Intensive Care Unit: A Retrospective Observational StudyPediatrics & Neonatology, 2016
- Ventilator-associated pneumonia in neonates, infants and childrenAntimicrobial Resistance & Infection Control, 2014
- Ventilator-Associated Pneumonia in Neonates: An UpdateNeoReviews, 2014
- Risk factors for ventilator-associated pneumonia in the neonatal intensive care unit: a meta-analysis of observational studiesEuropean Journal of Pediatrics, 2014
- Procalcitonin for discrimination between bacterial and viral lower re spiratory tract infectionsMenoufia Medical Journal, 2014
- Ventilator-associated pneumonia in the neonatal intensive care unitMenoufia Medical Journal, 2014
- Reduction of central line-associated bloodstream infection rates in a neonatal intensive care unit after implementation of a multidisciplinary evidence-based quality improvement collaborative: A four-year surveillanceCanadian Journal of Infectious Diseases and Medical Microbiology, 2013
- Strategies to Prevent Ventilator-Associated Pneumonia in NeonatesClinics in Perinatology, 2010
- Cytokines Associated With Bronchopulmonary Dysplasia or Death in Extremely Low Birth Weight InfantsPEDIATRICS, 2009
- Ventilator-Associated Pneumonia in Neonatal and Pediatric Intensive Care Unit PatientsClinical Microbiology Reviews, 2007